Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Jan 05, 2023

BUY
$118.38 - $210.04 $150,934 - $267,801
1,275 New
1,275 $229,000
Q2 2022

Jul 06, 2022

SELL
$117.13 - $176.59 $141,024 - $212,614
-1,204 Closed
0 $0
Q1 2022

Apr 13, 2022

BUY
$126.46 - $235.05 $48,307 - $89,789
382 Added 46.47%
1,204 $207,000
Q4 2021

Jan 10, 2022

BUY
$225.82 - $368.51 $24,388 - $39,799
108 Added 15.13%
822 $209,000
Q3 2021

Oct 13, 2021

BUY
$221.9 - $484.47 $158,436 - $345,911
714 New
714 $275,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14.4B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Capital Investment Advisors, LLC Portfolio

Follow Capital Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Advisors, LLC with notifications on news.